Bedminster, New Jersey, May 20, 2011

AMCS Corporation, a New Jersey based international supplier of industrial gases process plants, has entered into an agreement to supply the Italian Group SOL with a cryogenic Nitrogen Liquefier Unit having a nominal liquefaction capacity of 250 tons per day (TPD). The new Liquefier Unit will be integrated with an existing SOL plant in order to increase the production of liquid Oxygen and Nitrogen and enhancing the overall plant efficiency.

The new liquid Nitrogen plant will be an ULTRA-L-250TM, one of the ULTRA-LTM series of highly efficient standard liquid Nitrogen plants featuring AMCS' latest process cycle design, and offering attractively low life cycle costs. AMCS supplies the ULTRA-LTM plants over a broad product range of 25 and 800 TPD of liquid products.

"We are delighted to be working again with SOL, one of Europe's most dynamic and innovative industrial gases producers," said Ishmael Chalabi, President of AMCS, "This second project with SOL follows our successful delivery of an Ultra-N series plant to the Italian Group earlier this year. We view this new agreement, combined with our other recent wins in Europe and central Asia, as strong confirmation that we are adding recognized value for our customers".

AMCS Corporation supplies plants to the energy, chemicals, environmental, electronics and semiconductor, pharmaceuticals, glass, pulp and paper, and metals markets. Along with ASUs producing oxygen, nitrogen, argon, neon, helium, krypton, and xenon, AMCS supplies plants for high-purity electronic gases production, liquefied natural gas production, gas processing application and ship board process plants. As a full service engineered solution provider, AMCS has successfully executed turn-key projects in North America, Europe, South America, Middle East, and the Far East. AMCS' project and services capabilities, product portfolio, and references are available on its web site http://www.amcscorp.com

Founded in 1927, SOL S.p.A. is headquartered in Monza, Italy, and listed on the Milan Stock Exchange. It has about 2,000 employees and offices in 19 European countries and in India. The SOL Group specializes in the production of industrial and medical gases and related applications. The gases are used in industrial, civil and health care applications - in hospitals as well as at homes. SOL posted revenues of € 519 million in 2010.